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Chlorella virus CVK2 particles contain several capsid proteins that are selectively released by treatment with 4 M urea.
Seven of them (Vp52, Vp45, Vp41, Vp25, Vp20.5, Vp20, and Vp16.2) have been identified based on amino acid sequences
at the N-terminus. Comparison of the amino acid sequences with the corresponding ORFs deduced from the nucleotide
sequence of PBCV-1, the prototype member of Phycodnaviridae, revealed that the CVK2 proteins were processed at the N-
terminal region by two different proteolytic activities. q 1997 Academic Press
Large icosahedral viruses that infect green algal Chlo- M urea at 47 for 1 hr. The 4 M urea soluble fraction
contained 8 separate bands with molecular massesrella cells are widespread in natural fresh waters (for
review, see 9 and 10). Outstanding features of these (Mr) of 52, 45, 41, 25, 23, 20.5, 20, and 16.2 kDa, as
before (11). The proteins were electrotransferred ontoviruses (Phycodnaviridae; 2) include a linear, nonper-
muted dsDNA genome with hairpin ends, more than 50 a PVDF nylon filter (Immobilon, Millipore) with a Semi-
Dry transfer cell (Bio-Rad). Each protein band was sub-structural protein species in the virion, virus-encoded
DNA restriction and modification enzymes, virus-en- jected to N-terminal peptide sequence analysis on an
Applied Biosystems, Model 492 protein sequencer.coded protein glycosylation, genes with a group I self-
splicing intron, and a bacteriophage-like infection pro- The first 9 – 14 amino acid residues determined for 7
capsid proteins are listed in Table 1. For unknowncess (9, 10).
The 330-kb genome of PBCV-1, the prototype of this reasons, repeated experiments failed to sequence the
N-terminus of Vp23; the N-terminus of this protein mayviral family, is being sequenced (4–6) and 189 major
ORFs have been identified, so far. be modified.
Computer-aided comparison of these sequences withChlorella virus CVK2 is a member of this family that
was isolated in Japan (12). Previously, we found that those of ORFs deduced from the nucleotide sequence
several proteins, including the major capsid protein Vp52, determined for PBCV-1 resulted in a one-to-one corre-
were selectively released from CVK2 virions by treatment spondence except for Vp16.2 as shown in Table 1. As
with 4 M urea (11). Some of these proteins were labeled expected, the N-terminal 11 amino acids of the major
by treatment of intact virions with 125I and lactoperoxi- protein Vp52 were identical to the first 11 amino acids
dase. We supposed, therefore, that the outermost enve- of PBCV-1 Vp54. Vp54, which is characterized as the
lope of the virion was destroyed by 4 M urea treatment major capsid protein of PBCV-1, is myristylated as well
and that its constituents (about 10 proteins) were sepa- as glycosylated and comprises about 40% of the total
rated from the DNA-containing viral core. In this work, PBCV-1 structural proteins (3, 7, 8).
we have further characterized the individual capsid pro- Vp45 of CVK2 had nearly the same N-terminal peptide
teins of CVK2 by determining their N-terminal amino acid sequence as Vp52; the only difference being that Vp45
sequences and comparing them with the deduced amino lacked the most terminal methionine residue found in
acid sequences from the PBCV-1 ORFs. Vp52 (Fig. 1A). This modification might be due to methio-
As previously reported (11), CVK2 proteins were sep- nine aminopeptidase, which is involved in the processing
arated by 12.5% SDS – polyacrylamide gel electropho- of some viral proteins (1). When the intact virus is labeled
resis after treating the purified CVK2 particles with 4 with 125I by lactoperoxidase, both Vp52 and Vp45 are
specifically labeled, indicating that the two proteins are
on the virion surface (11). Judging by inactivity with1 To whom correspondence and reprint requests should be ad-
Schiff’s reagent (data not shown), Vp45 does not appeardressed. Fax: /81(824)24-7752. E-mail: tayamad@ipc.hiroshima-
u.ac.jp. to be glycosylated, therefore, it would be interesting to
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investigate a relationship between the demethionine pro-
cessing and glycosylation.
The Vp41 sequence has a moderate level of homology
with the N-terminal region of the PBCV-1 A625L ORF.
The ORF A625L is homologous with the PBCV-1 major
capsid protein (3, 7) as well as with the major capsid
protein from some iridoviruses (J. L. Van Etten, personal
communication). In contrast to Vp52 and Vp45, Vp41 was
not labeled with 125I by lactoperoxidase so that this pro-
tein seems to be embedded in the CVK2 capsid. The N-
terminus of Vp41 was alanine, and the terminal methio-
nine (possibly with a few amino acid residues) was also
removed (Fig. 1A).
Vp25 and Vp20 were identified as homologues of
A203R and A168R of PBCV-1 (4), respectively. However,
the N-terminal amino acid of Vp25 corresponded to the
Phe26 (F26) of A203R, and Vp20’s N-terminus was equiva-
lent to Glu31 of A168R (Fig. 1B). A168R is described as a
protein with a transmembrane sequence (aa 7–23) (4). A
30-aa N-terminal region including this highly hydrophobic FIG. 1. N-terminal amino acid sequences of CVK2 capsid proteins
sequence (17 aa residues) was removed from Vp20. This compared with ORFs deduced from the PBCV-1 DNA sequence. (A)
The N-terminal methionine of Vp45, Vp41, and Vp20.5 is presumablyis also the case for Vp25 where an N-terminal region
removed by a methionine aminopeptidase-like activity. (B) A signalmissing 25 aa contains a highly hydrophobic sequence
peptidase-like processing activity presumably removes the N-terminalof 17 aa residues (aa 2 –18; Fig. 1B). A lysine with an
25–30 aa of Vp25 and Vp20 that contains a highly hydrophobic se-
acidic amino acid on its N-side preceeds the cleavage quence of 17 aa (underlined). Lysine with an acidic amino acid on the
point in both cases. This kind of cleavage, therefore, is N-side (double underlined) always precedes the cleavage site. Arrow
indicates the cleavage site.very similar to the flavivirus protein processing by signal
peptidase in the lumen of rough endoplasmic reticulum
(1). Here, involvement of the membrane structure in Chlo- In the case of Vp20.5, the N-terminal peptide sequence
rella virus assembly is strongly suggested. Although the showed significant homology with that of the PBCV-1
primary sequences of Vp25 and Vp20 are totally different, A523R ORF (Fig. 1A). A523R is predicted to encode a
their amino acid composition and predicted secondary protein of 171 aa with a Mr 19,095, which is similar to
structure are very similar. The characteristic N-terminal the 20.5-kDa size of Vp20.5. There is no information about
structure with a highly hydrophobic sequence followed the function of this protein. The N-terminal methionine of
by a putative cleavage site was also found in several Vp20.5 is also removed, possibly by methionine amino-
other PBCV-1 ORFs, for example, A130R, A157L, and peptidase (Fig. 1A).
A320R (4, 5). The N-terminal amino acid sequence of Vp16.2 did not
have any significant homology with ORFs identified on
the PBCV-1 genome. This protein may be a viral species-TABLE 1
specific protein.
N-Terminal Amino Acid Sequences of the CVK2 Capsid Proteins Unlike the capsid proteins, the N-terminal peptide se-
quence (10 aa) of Vp35, one of the CVK2 core proteinsCorresponding ORF of
that has a protein kinase activity (11), exactly matchedProtein Amino acid sequence PBCV-1 (positions)a
the first 10 amino acid sequences of PBCV-1 A34R
VP52 MAGGLSQLVAY Vp54 (1–11) (Table 1).
Vp45 AGGLSQLVAY Vp54 (2–11) These results lead to the following questions: (i) What
Vp41 AGIMQLVSTG A625Lb (5–12)
enzymes (either of viral or host origin) are responsibleVp25 FVVVGKFVEP A203R (26–35)
for processing the Chlorella virus capsid proteins? (ii)Vp20.5 AIMKTQRLENVLFQ A523Rb (2–14)
When, where, and how does processing occur in theVp20 EDSINEYAAPVNR A168R (31–43)
Vp16.2 AIMKYQANE NIc course of Chlorella virus replication? (iii) What are the
Vp35 MYPRPEKSKS A34R (1–10) biological effects of processing?
a Corresponding amino acid positions. ACKNOWLEDGMENTSb The sequence is to be available from the GenBank Database under
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